Skip to content

Relmada Therapeutics, Inc. RLMD Nontaxable or nondeductible items

Nontaxable or nondeductible items at other companies

NWN
Northwest NaturalNWN
1.1%+0.4pp
ARD
Ardent Health PartnersARDT
0.3%-0.1pp
Virtu Financial logo
Virtu FinancialVIRT
0%
Blackbaud logo
BlackbaudBLKB
0%0.0pp
Popular logo
PopularBPOP
-19.4%
Skyline Champion logo
Skyline ChampionSKY
0.5%

Other financials

Income statement

See full
Operating income-$19.5M-6.8%
Net income-$19.1M-8.5%
EPS (diluted)-$0.22+62.1%

Balance sheet

See full
Cash & equivalents$9.8M+750%
Total debt$104.1M-40.4%
Total equity$218.7M+875%
Total assets$235.4M+750%

Cash flow

See full
Operating cash flow-$15.1M+16.6%

Valuation

See full
Market cap$677.17M+2,907%

Returns & leverage

See full
Return on equity-48.8%-20.0pp
Debt / equity0.9×0.0×
Current ratio18.3×+13.0×

Where this comes from

Reported directly by Relmada Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense.

The official record: Relmada Therapeutics, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relmada Therapeutics, Inc.'s nontaxable or nondeductible items.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Relmada Therapeutics, Inc.'s nontaxable or nondeductible items?
Relmada Therapeutics, Inc. (RLMD) reported nontaxable or nondeductible items of -2.6% in Q4 2024.
What does nontaxable or nondeductible items mean?
This metric tracks the company's share of profits or losses from investments in affiliated entities or joint ventures. It provides visibility into the financial performance of non-consolidated business interests.